Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Biofactors ; 41(6): 391-402, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26643647

RESUMEN

Dietary leucine was incrementally restricted to test whether limiting this essential amino acid (EAA) would fully reproduce the beneficial responses produced by dietary methionine restriction. Restricting leucine by 85% increased energy intake and expenditure within 5 to 7 days of its introduction and reduced overall accumulation of adipose tissue. Leucine restriction (LR) also improved glucose tolerance, increased hepatic release of fibroblast growth factor 21 into the blood stream, and enhanced insulin-dependent activation of Akt in liver. However, LR had no effect on hepatic lipid levels and failed to lower lipogenic gene expression in the liver. LR did affect remodeling of white and brown adipose tissues, increasing expression of both thermogenic and lipogenic genes. These findings illustrate that dietary LR reproduces many but not all of the physiological responses of methionine restriction. The primary differences occur in the liver, where methionine and LR cause opposite effects on tissue lipid levels and expression of lipogenic genes. Altogether, these findings suggest that the sensing systems which detect and respond to dietary restriction of EAAs act through mechanisms that both leucine and methionine are able to engage, and in the case of hepatic lipid metabolism, may be unique to specific EAAs such as methionine.


Asunto(s)
Tejido Adiposo/metabolismo , Aminoácidos Esenciales/metabolismo , Insulina/genética , Leucina/metabolismo , Metionina/metabolismo , Tejido Adiposo/efectos de los fármacos , Aminoácidos Esenciales/administración & dosificación , Animales , Suplementos Dietéticos , Factores de Crecimiento de Fibroblastos/biosíntesis , Factores de Crecimiento de Fibroblastos/genética , Glucosa/metabolismo , Humanos , Insulina/metabolismo , Hígado/metabolismo , Metionina/administración & dosificación , Ratones , Transducción de Señal
2.
Psychoneuroendocrinology ; 36(2): 266-78, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20724079

RESUMEN

Contrary to the reduction of depressive-like behavior observed in several strains of cytokine receptor knockout mice, mice lacking the specific receptor for interleukin (IL)-15 showed increased immobility in tail suspension and modified forced swimming tests. There was also a reduction in social interactions. The hippocampus of the IL15Rα knockout mice had decreased mRNA for 5-HT(1A), increased mRNA for 5-HT(2C), and region-specific changes of serotonin reuptake transporter (SERT) immunoreactivity. Fluoxetine (the classic antidepressant Prozac, which inhibits 5-HT(2C) and SERT) reduced the immobility of the IL15Rα knockout mice in comparison with their pretreatment baseline. Together with the unchanged performance of the IL15Rα knockout mice on the rotarod, this response to fluoxetine indicates that the immobility reflects depression. Wildtype mice responded to IL15 treatment with improvement of immobility induced by forced swimming, whereas the knockout mice failed to respond. Thus, the cognate IL15 receptor is necessary for the antidepressive activity of IL15. In ex vivo studies, IL15 decreased synaptosomal uptake of 5-HT, and modulated the expression of 5-HT(2C) and SERT in cultured neurons in a dose- and time-dependent manner. Thus, the effect of IL15 on serotonin transmission may underlie the depressive-like behavior of IL15Rα knockout mice. We speculate that IL15 is essential to maintain neurochemical homeostasis and thereby plays a role in preventing neuropsychiatric symptoms.


Asunto(s)
Antidepresivos/farmacología , Depresión/prevención & control , Interleucina-15/farmacología , Sistema Nervioso/efectos de los fármacos , Serotonina/metabolismo , Animales , Células Cultivadas , Depresión/genética , Depresión/metabolismo , Depresión/patología , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Fluoxetina/farmacología , Reacción Cataléptica de Congelación/efectos de los fármacos , Reacción Cataléptica de Congelación/fisiología , Interleucina-15/fisiología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Sistema Nervioso/metabolismo , Receptores de Interleucina-15/agonistas , Receptores de Interleucina-15/genética , Receptores de Interleucina-15/metabolismo , Receptores de Interleucina-15/fisiología , Transmisión Sináptica/efectos de los fármacos , Transmisión Sináptica/genética , Transmisión Sináptica/fisiología , Sinaptosomas/efectos de los fármacos , Sinaptosomas/metabolismo , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA